Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04668417 · ClinicalTrials.gov registry record · NA
Pediatric Second Influenza Dose Portal Reminder Recall
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 698
- Enrollment target
NCT04668417 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 698 participants.
The verdict
NCT04668417, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 698 participants
- Enrollment target
Study Summary
This trial is taking place in Los Angeles, CA among patients from primary care practices within the UCLA Health System. The study design is a parallel 2-arm trial. The parallel arms are 1) a reminder letter for the second dose of influenza vaccine (reminder messages sent via the patient portal) with a direct appointment scheduling link included in the reminder and 2) a reminder letter for the second dose of influenza vaccine, but no direct appointment scheduling link included.
Interventions
- BEHAVIORAL Portal Reminders for Second Dose of Influenza Vaccine with Direct Scheduling Link
- BEHAVIORAL Portal Reminders for Second Dose of Influenza Vaccine without Direct Scheduling Link
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 698 participants |
| Start Date | 2020-12-15 |
| Est. Completion | 2021-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04668417
The ClinicalTrials.gov registry entry for NCT04668417 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 698 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Portal Reminders for Second Dose of Influenza Vaccine with Direct Scheduling Link is the first listed.
NCT04668417 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04668417 about?
NCT04668417 is a clinical study titled "Pediatric Second Influenza Dose Portal Reminder Recall". This trial is taking place in Los Angeles, CA among patients from primary care practices within the UCLA Health System. The study design is a parallel 2-arm trial. The parallel arms are 1) a reminder letter for the second dose of influenza vaccine (reminder messages sent via the patient portal) wit...
What is the current status of trial NCT04668417?
This trial is currently completed. It is a NA study. The enrollment target is 698 participants. The study started on 2020-12-15. Estimated completion is 2021-04-01.
What interventions are being tested in trial NCT04668417?
The interventions under investigation include: Portal Reminders for Second Dose of Influenza Vaccine with Direct Scheduling Link (BEHAVIORAL), Portal Reminders for Second Dose of Influenza Vaccine without Direct Scheduling Link (BEHAVIORAL).
Who is sponsoring clinical trial NCT04668417?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.